34 participants
BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-10
- Start Date:
- 2026-10-01
- Completion:
- 2028-02-01
Conditions
- Multiple Myeloma
Interventions
- DRUG
No Results Yet